Study of antihyperglycaemic activity in streptozotocin induced diabetic mice and antioxidant activities of medicinal plant extracts
Author affiliations
DOI:
https://doi.org/10.15625/0866-7160/v41n2.13783Keywords:
DPPH, Diabetes, Antihyperglycemic activity, a-Glucosidase inhibitor, α-Amylase inhibitor.Abstract
Some extracts of medicinal plants have demonstrated potential benefits in treatment of different diseases for centuries such as antihyperglycemic, antioxidant, anti-inflammatory, antibacterial. The purpose of this study is to evaluate the effect of extracts from several herbal plants, such as Gymnema sylvestre, Stevia rebaudiana, Cinnamomum cassia, Zea may, Ocimum basilicumon blood glucose level in streptozotocin (STZ) induced diabetic miceand to offer scientific proofs for the identified antihyperglycemic effect by investigating on mechanismsof the most effective extract. The results proved that diabetic mice treated with 70% ethanol extracts of Gymnema sylvestre leaves and Stevia rebaudiana leaves showed significant reduction of the blood glucose levels at a dose of 500 mg/kg body weight when compared to control (p<0,05). Antihyperglycemic activity of Gymnema sylvestre (57,68%) and Stevia rebaudiana extracts (54,93%) were significantly higher than other extracts. The inhibition of α-amylase and α-glucosidase activity of Gymnema sylvestreand, Stevia rebaudiana extracts were carried out in vitro. The result demonstrated that these Gymnema sylvestre and Stevia rebaudiana extracts exerted significant inhibition and specific on intestinal α-amylase and α-glucosidases activities. Using 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay showed that Gymnema sylvestre and Stevia rebaudiana extracts exhibited relatively low antioxidant activity with the concentration of a sample required for 50% scavenging of the DPPH free radical of 115,88 ± 1,16 µg/ml and 160,27 ± 2,01 µg/mlcompared to vitamin C (49,16 ± 1,26 µg/ml).
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Academia Journal of Biology (AJB) is an open-access and peer-reviewed journal. The articles published in the AJB are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits for immediate free access to the articles to read, download, copy, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited (with a link to the formal publication through the relevant DOI), and without subscription charges or registration barriers. The full details of the CC BY-NC-ND 4.0 License are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.